For doctors

Sarcoma: trials for referral

632 open trials in the registries we read. Each row links to its registry record.

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Sarcoma·What we know·Glossary

Where the open trials are

Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.

Your city

Only trials with a pre-treatment window

400 trials shown · Showing the 400 most recently updated of 632 open trials.

No phase16 sites
RecruitingItaly
NCT04890067
Observational Study in Localized Osteosarcoma
Italian Sarcoma Group
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 11 site
RecruitingUnited States
NCT06474676
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
M.D. Anderson Cancer Center
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT06375122
Natural History Study of Kaposi Sarcoma
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT06176989
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 11 site
Not yet recruitingGermany
NCT07897968
GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
Universität Münster
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT06222203
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT07428993
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
St. Jude Children's Research Hospital
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 11 site
RecruitingUnited States
NCT02390752
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
National Cancer Institute (NCI)
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 211 sites
RecruitingSpain, Italy
NCT07328425
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Italian Sarcoma Group
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase4 sites
RecruitingCanada, United States
NCT07227961
Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
University of Calgary
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/21 site
Not yet recruitingChina
NCT04433221
Combination Immunotherapy Targeting Sarcomas
Shenzhen Geno-Immune Medical Institute
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 116 sites
RecruitingUnited States
NCT05711615
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
National Cancer Institute (NCI)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 12 sites
RecruitingUnited States
NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
National Cancer Institute (NCI)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Early Phase 11 site
RecruitingUnited States
NCT07658768
Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
Abramson Cancer Center at Penn Medicine
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT07283731
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 15 sites
RecruitingGermany
NCT06839703
International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Prof. Dr. Dr. Birgit Burkhardt
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 10 sites
Not yet recruiting
NCT07905924
A Study to Evaluate the Safety and Effectiveness of Different Doses of RO7836748 Alone or in Combination With Other Cancer Therapies in People With Solid Tumors With a Rat Sarcoma Viral Oncogene Homolog Glycine 12 Valine (RAS G12V) Mutation
Hoffmann-La Roche
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/21 site
Not yet recruitingChina
NCT03356782
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Shenzhen Geno-Immune Medical Institute
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/272 sites
RecruitingAustralia, Belgium, Brazil, Canada, Chile, Colombia
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Merck Sharp & Dohme LLC
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
Not yet recruitingChina
NCT07902011
CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support
China-Japan Friendship Hospital
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 113 sites
RecruitingAustralia, United States
NCT07297979
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Amgen
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Cancer Institute (NCI)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
Not yet recruitingUnited States
NCT07516353
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT04557969
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
National Cancer Institute (NCI)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/210 sites
RecruitingSpain
2024-520318-23-00
Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas
Registry updated 28 Oct 2026
Registry record: EU CTIS
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Sanford Health
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 232 sites
RecruitingUnited States
NCT04616560
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
National Cancer Institute (NCI)
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/216 sites
RecruitingUnited States
NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/241 sites
RecruitingArgentina, China, Czechia, United Kingdom, Japan, Mexico
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Pfizer
Registry updated 28 Oct 2026 · The registries disagree on the status
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 112 sites
RecruitingAustralia, United Kingdom, United States
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
MacroGenics
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site

771 sites Pre-treatment window

The same sites as a list

United States250 open trials
China42 open trials
France40 open trials
Canada33 open trials
Spain28 open trials
Italy23 open trials
Germany19 open trials
United Kingdom19 open trials
Australia19 open trials
Netherlands16 open trials
Denmark15 open trials
Japan13 open trials
South Korea12 open trials
Poland11 open trials
Belgium9 open trials
Sweden8 open trials
Brazil6 open trials
Israel6 open trials
Greece6 open trials
Czechia5 open trials
Taiwan5 open trials
Austria5 open trials
Switzerland5 open trials
Colombia4 open trials
Argentina4 open trials
New Zealand4 open trials
Hong Kong SAR China4 open trials
Singapore4 open trials
Chile3 open trials
Hungary3 open trials
Mexico3 open trials
Finland3 open trials
Norway3 open trials
Portugal3 open trials
Uganda3 open trials
Slovakia2 open trials
Ukraine2 open trials
India2 open trials
Puerto Rico2 open trials
Georgia1 open trials
Romania1 open trials
Costa Rica1 open trials
Bulgaria1 open trials
Ireland1 open trials
Cyprus1 open trials
Zimbabwe1 open trials
Kenya1 open trials
Moldova1 open trials
Thailand1 open trials
Malawi1 open trials
Saudi Arabia1 open trials
Jordan1 open trials

Who treats this

Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.

Agostino Gemelli University Polyclinic
Rome, Italy
1 trials · 57 publications · ROR
Albert Einstein College of Medicine
Bronx, United States
0 trials · 44 publications · ROR
All India Institute of Medical Sciences
New Delhi, India
2 trials · 130 publications · ROR
Amsterdam University Medical Centers
Amsterdam, Netherlands
1 trials · 48 publications · ROR
Assistance Publique – Hôpitaux de Paris
Paris, France
10 trials · 84 publications · ROR
Azienda Ospedale - Università Padova
Padua, Italy
5 trials · 56 publications · ROR
Bambino Gesù Children's Hospital
Rome, Italy
5 trials · 50 publications · ROR
Baylor College of Medicine
Houston, United States
2 trials · 99 publications · ROR
Boston Children's Hospital
Boston, United States
9 trials · 44 publications · ROR
Brigham and Women's Hospital
Boston, United States
9 trials · 115 publications · ROR
Broad Institute
Cambridge, United States
0 trials · 40 publications · ROR
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, China
0 trials · 50 publications · ROR
Capital Medical University
Beijing, China
0 trials · 91 publications · ROR
Case Western Reserve University
Cleveland, United States
7 trials · 56 publications · ROR
Cedars-Sinai Medical Center
Los Angeles, United States
24 trials · 56 publications · ROR
Center for Cancer Research
Bethesda, United States
0 trials · 65 publications · ROR
Central South University
Changsha, China
0 trials · 46 publications · ROR
Centre Léon Bérard
Lyon, France
75 trials · 159 publications · ROR
Centre National de la Recherche Scientifique
Paris, France
0 trials · 107 publications · ROR
Centre Oscar Lambret
Lille, France
27 trials · 60 publications · ROR
Charité – Universitätsmedizin Berlin
Berlin, Germany
2 trials · 68 publications · ROR
Charles University
Prague, Czechia
0 trials · 49 publications · ROR
Children's Hospital of Philadelphia
Philadelphia, United States
45 trials · 75 publications · ROR
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
0 trials · 112 publications · ROR
City Of Hope National Medical Center
Duarte, United States
6 trials · 47 publications · ROR
Cleveland Clinic
Cleveland, United States
13 trials · 133 publications · ROR
Columbia University Irving Medical Center
New York, United States
10 trials · 45 publications · ROR
Dana-Farber Cancer Institute
Boston, United States
99 trials · 147 publications · ROR
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, United States
0 trials · 54 publications · ROR
Deutsches Konsortium für Translationale Krebsforschung
Heidelberg, Germany
0 trials · 108 publications · ROR
Duke Medical Center
Durham, United States
39 trials · 67 publications · ROR
Duke University
Durham, United States
8 trials · 91 publications · ROR
Emory University
Atlanta, United States
2 trials · 92 publications · ROR
Essen University Hospital
Essen, Germany
3 trials · 96 publications · ROR
Fondation Gustave Roussy
Villejuif, France
0 trials · 49 publications · ROR
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
30 trials · 199 publications · ROR
Fred Hutch Cancer Center
Seattle, United States
12 trials · 63 publications · ROR
Frederick National Laboratory for Cancer Research
Frederick, United States
0 trials · 48 publications · ROR
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
0 trials · 49 publications · ROR
Fudan University
Shanghai, China
0 trials · 109 publications · ROR
Fudan University Shanghai Cancer Center
Shanghai, China
7 trials · 62 publications · ROR
German Cancer Research Center
Heidelberg, Germany
0 trials · 155 publications · ROR
Harvard University
Cambridge, United States
0 trials · 246 publications · ROR
Heidelberg University
Heidelberg, Germany
0 trials · 112 publications · ROR
Homi Bhabha National Institute
Mumbai, India
0 trials · 69 publications · ROR
Hôpital Cochin
Paris, France
4 trials · 48 publications · ROR
Hôpital de la Timone
Marseille, France
7 trials · 42 publications · ROR
Hopp Children's Cancer Center Heidelberg
Heidelberg, Germany
0 trials · 91 publications · ROR
Hospital de Sant Pau
Barcelona, Spain
21 trials · 60 publications · ROR
Hospital for Sick Children
Toronto, Canada
13 trials · 71 publications · ROR
Hospital General Universitario Gregorio Marañón
Madrid, Spain
17 trials · 45 publications · ROR
Hospital Universitari i Politècnic La Fe
Valencia, Spain
2 trials · 49 publications · ROR
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
26 trials · 59 publications · ROR
Hospital Universitario Virgen del Rocío
Seville, Spain
6 trials · 44 publications · ROR
Huazhong University of Science and Technology
Wuhan, China
0 trials · 73 publications · ROR
Humanitas University
Rozzano, Italy
0 trials · 41 publications · ROR
Huntsman Cancer Institute
Salt Lake City, United States
21 trials · 41 publications · ROR
Icahn School of Medicine at Mount Sinai
New York, United States
3 trials · 44 publications · ROR
Indiana University Indianapolis
Indianapolis, United States
0 trials · 53 publications · ROR
Indiana University School of Medicine
Indianapolis, United States
1 trials · 76 publications · ROR
Inserm
Paris, France
0 trials · 198 publications · ROR
Institut Bergonié
Bordeaux, France
48 trials · 95 publications · ROR
Institut Curie
Paris, France
30 trials · 153 publications · ROR
Institut Gustave Roussy
Villejuif, France
52 trials · 155 publications · ROR
Institut universitaire du cancer de Toulouse Oncopole
Toulouse, France
1 trials · 41 publications · ROR
Institute of Cancer Research
London, United Kingdom
0 trials · 110 publications · ROR
IRCCS Humanitas Research Hospital
Rozzano, Italy
0 trials · 56 publications · ROR
Istanbul University
Istanbul, Türkiye
0 trials · 54 publications · ROR
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
0 trials · 70 publications · ROR
Istituto Oncologico Veneto
Padua, Italy
9 trials · 42 publications · ROR
Istituto Ortopedico Rizzoli
Bologna, Italy
16 trials · 90 publications · ROR
Johns Hopkins Medicine
Baltimore, United States
0 trials · 79 publications · ROR
Johns Hopkins University
Baltimore, United States
11 trials · 157 publications · ROR
Karolinska Institutet
Stockholm, Sweden
0 trials · 49 publications · ROR
KU Leuven
Leuven, Belgium
0 trials · 54 publications · ROR
Leiden University Medical Center
Leiden, Netherlands
6 trials · 104 publications · ROR
LMU Klinikum
Munich, Germany
0 trials · 57 publications · ROR
Ludwig-Maximilians-Universität München
Munich, Germany
1 trials · 96 publications · ROR
Lyon 1 Université
Villeurbanne, France
0 trials · 48 publications · ROR
Massachusetts General Hospital
Boston, United States
26 trials · 155 publications · ROR
Mayo Clinic
Rochester, United States
20 trials · 218 publications · ROR
Mayo Clinic in Florida
Jacksonville, United States
19 trials · 55 publications · ROR
McGill University
Montreal, Canada
0 trials · 56 publications · ROR
Medical College of Wisconsin
Milwaukee, United States
13 trials · 51 publications · ROR
Medical University of Graz
Graz, Austria
4 trials · 46 publications · ROR
Medical University of Vienna
Vienna, Austria
2 trials · 66 publications · ROR
Memorial Sloan Kettering Cancer Center
New York, United States
99 trials · 292 publications · ROR
Ministry of Health of the Russian Federation
Moscow, Russia
0 trials · 67 publications · ROR
Moffitt Cancer Center
Tampa, United States
29 trials · 115 publications · ROR
Mohammed V University
Rabat, Morocco
0 trials · 44 publications · ROR
Mount Sinai Hospital
Toronto, Canada
5 trials · 66 publications · ROR
Nanjing Medical University
Nanjing, China
0 trials · 47 publications · ROR
National and Kapodistrian University of Athens
Athens, Greece
0 trials · 61 publications · ROR
National Cancer Center Hospital
Tokyo, Japan
15 trials · 96 publications · ROR
National Cancer Institute
Bethesda, United States
2 trials · 174 publications · ROR
National Center for Tumor Diseases
Heidelberg, Germany
1 trials · 86 publications · ROR
National Institutes of Health
Bethesda, United States
1 trials · 123 publications · ROR
National University of Singapore
Singapore, Singapore
0 trials · 42 publications · ROR
Nationwide Children's Hospital
Columbus, United States
40 trials · 90 publications · ROR
Northwestern University
Evanston, United States
25 trials · 89 publications · ROR
Oregon Health & Science University
Portland, United States
10 trials · 69 publications · ROR
Oslo University Hospital
Oslo, Norway
3 trials · 41 publications · ROR
Peking University Cancer Hospital
Beijing, China
8 trials · 50 publications · ROR
Peking University People's Hospital
Beijing, China
14 trials · 53 publications · ROR
Peter MacCallum Cancer Centre
Melbourne, Australia
10 trials · 58 publications · ROR
Princess Margaret Cancer Centre
Toronto, Canada
20 trials · 118 publications · ROR
Princess Máxima Center
Utrecht, Netherlands
0 trials · 112 publications · ROR
Radboud University Medical Center
Nijmegen, Netherlands
6 trials · 48 publications · ROR
Rigshospitalet
Copenhagen, Denmark
12 trials · 43 publications · ROR
Roswell Park Comprehensive Cancer Center
Buffalo, United States
48 trials · 41 publications · ROR
Royal Marsden Hospital
London, United Kingdom
10 trials · 103 publications · ROR
Royal Marsden NHS Foundation Trust
London, United Kingdom
0 trials · 78 publications · ROR
Russian Cancer Research Center NN Blokhin
Moscow, Russia
0 trials · 53 publications · ROR
Sağlık Bilimleri Üniversitesi
Istanbul, Türkiye
0 trials · 50 publications · ROR
Sapienza University of Rome
Rome, Italy
0 trials · 54 publications · ROR
Second Affiliated Hospital of Zhejiang University
Hangzhou, China
0 trials · 45 publications · ROR
Shandong First Medical University
Jinan, China
0 trials · 40 publications · ROR
Shanghai Jiao Tong University
Shanghai, China
0 trials · 105 publications · ROR
Shanghai Medical College of Fudan University
Shanghai, China
0 trials · 58 publications · ROR
Sichuan University
Chengdu, China
0 trials · 74 publications · ROR
Southern Medical University
Guangzhou, China
0 trials · 46 publications · ROR
St. Jude Children's Research Hospital
Memphis, United States
23 trials · 128 publications · ROR
Stanford Medicine
Stanford, United States
3 trials · 124 publications · ROR
Stanford University
Stanford, United States
7 trials · 161 publications · ROR
Sun Yat-sen University
Guangzhou, China
0 trials · 80 publications · ROR
Sun Yat-sen University Cancer Center
Guangzhou, China
22 trials · 56 publications · ROR
Sylvester Comprehensive Cancer Center
Miami, United States
1 trials · 55 publications · ROR
Tata Memorial Hospital
Mumbai, India
0 trials · 74 publications · ROR
Technical University of Munich
Munich, Germany
0 trials · 54 publications · ROR
Tehran University of Medical Sciences
Tehran, Iran
0 trials · 41 publications · ROR
The Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
1 trials · 100 publications · ROR
The Netherlands Cancer Institute
Amsterdam, Netherlands
8 trials · 92 publications · ROR
The Ohio State University
Columbus, United States
3 trials · 146 publications · ROR
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, United States
0 trials · 55 publications · ROR
The Ohio State University Wexner Medical Center
Columbus, United States
4 trials · 57 publications · ROR
The University of Melbourne
Melbourne, Australia
0 trials · 45 publications · ROR
The University of Sydney
Sydney, Australia
0 trials · 59 publications · ROR
The University of Texas Health Science Center at Houston
Houston, United States
0 trials · 46 publications · ROR
The University of Texas MD Anderson Cancer Center
Houston, United States
20 trials · 368 publications · ROR
The University of Texas Southwestern Medical Center
Dallas, United States
5 trials · 117 publications · ROR
Universidade de São Paulo
São Paulo, Brazil
0 trials · 44 publications · ROR
Università Cattolica del Sacro Cuore
Milan, Italy
0 trials · 48 publications · ROR
Universitätsklinikum Erlangen
Erlangen, Germany
1 trials · 52 publications · ROR
Universitätsklinikum Tübingen
Tübingen, Germany
6 trials · 48 publications · ROR
Université de Bordeaux
Bordeaux, France
1 trials · 50 publications · ROR
Université Paris Cité
Paris, France
0 trials · 70 publications · ROR
Université Paris Sciences et Lettres
Paris, France
0 trials · 65 publications · ROR
Université Paris-Saclay
Gif-sur-Yvette, France
0 trials · 69 publications · ROR
University College London
London, United Kingdom
0 trials · 89 publications · ROR
University College London Hospitals NHS Foundation Trust
London, United Kingdom
4 trials · 43 publications · ROR
University Health Network
Toronto, Canada
5 trials · 95 publications · ROR
University Hospital Heidelberg
Heidelberg, Germany
5 trials · 134 publications · ROR
University Hospital Münster
Münster, Germany
2 trials · 48 publications · ROR
University Hospital Zurich
Zurich, Switzerland
1 trials · 43 publications · ROR
University Medical Center Groningen
Groningen, Netherlands
10 trials · 41 publications · ROR
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
9 trials · 47 publications · ROR
University Medical Center Utrecht
Utrecht, Netherlands
4 trials · 93 publications · ROR
University Medical Centre Mannheim
Mannheim, Germany
2 trials · 47 publications · ROR
University of Alabama at Birmingham
Birmingham, United States
5 trials · 44 publications · ROR
University of Arkansas for Medical Sciences
Little Rock, United States
7 trials · 40 publications · ROR
University of Birmingham
Birmingham, United Kingdom
0 trials · 51 publications · ROR
University of Bologna
Bologna, Italy
0 trials · 69 publications · ROR
University of British Columbia
Vancouver, Canada
0 trials · 70 publications · ROR
University of Calgary
Calgary, Canada
2 trials · 42 publications · ROR
University of California San Diego
San Diego, United States
5 trials · 63 publications · ROR
University of California, Davis
Davis, United States
2 trials · 40 publications · ROR
University of California, Los Angeles
Los Angeles, United States
8 trials · 117 publications · ROR
University of California, San Francisco
San Francisco, United States
12 trials · 119 publications · ROR
University of Colorado Anschutz
Aurora, United States
0 trials · 98 publications · ROR
University of Florida
Gainesville, United States
8 trials · 84 publications · ROR
University of Iowa
Iowa City, United States
3 trials · 42 publications · ROR
University of Miami
Coral Gables, United States
11 trials · 113 publications · ROR
University of Michigan
Ann Arbor, United States
17 trials · 71 publications · ROR
University of Milan
Milan, Italy
0 trials · 72 publications · ROR
University of Minnesota
Minneapolis, United States
6 trials · 74 publications · ROR
University of North Carolina at Chapel Hill
Chapel Hill, United States
3 trials · 96 publications · ROR
University of Oxford
Oxford, United Kingdom
0 trials · 47 publications · ROR
University of Padua
Padua, Italy
0 trials · 104 publications · ROR
University of Pennsylvania
Philadelphia, United States
6 trials · 146 publications · ROR
University of Pittsburgh
Pittsburgh, United States
0 trials · 92 publications · ROR
University of Pittsburgh Medical Center
Pittsburgh, United States
6 trials · 91 publications · ROR
University of South Florida
Tampa, United States
2 trials · 44 publications · ROR
University of Southern California
Los Angeles, United States
3 trials · 78 publications · ROR
University of Toronto
Toronto, Canada
0 trials · 177 publications · ROR
University of Tübingen
Tübingen, Germany
0 trials · 60 publications · ROR
University of Turin
Turin, Italy
0 trials · 53 publications · ROR
University of Utah
Salt Lake City, United States
6 trials · 52 publications · ROR
University of Washington
Seattle, United States
2 trials · 124 publications · ROR
University of Zurich
Zurich, Switzerland
0 trials · 74 publications · ROR
UNSW Sydney
Sydney, Australia
0 trials · 54 publications · ROR
UPMC Hillman Cancer Center
Pittsburgh, United States
14 trials · 40 publications · ROR
Utrecht University
Utrecht, Netherlands
0 trials · 54 publications · ROR
Vall d'Hebron Hospital Universitari
Barcelona, Spain
0 trials · 82 publications · ROR
Vanderbilt University Medical Center
Nashville, United States
10 trials · 41 publications · ROR
Washington University in St. Louis
St Louis, United States
17 trials · 94 publications · ROR
Weill Cornell Medicine
New York, United States
0 trials · 101 publications · ROR
West China Hospital of Sichuan University
Chengdu, China
2 trials · 56 publications · ROR
Yale University
New Haven, United States
37 trials · 64 publications · ROR
Zhejiang University
Hangzhou, China
0 trials · 95 publications · ROR
Zhengzhou University
Zhengzhou, China
0 trials · 41 publications · ROR

What changed in the last 7 days

RSS feed (30 days)Calendar reminder

Registry facts, one per line, newest first.

No registry change in the last 7 days.

Results card

Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.

No phaseEnded 14 Oct 2026
Completed11 participants
NCT06904365
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Registry record
Phase 4Ended 9 Sept 2026
Completed20 participants
NCT03144206
Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study
Registry record
Phase 3Ended 7 Sept 2026
Completed122 participants
NCT06935409
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Registry record
Phase 1Ended 7 Sept 2026
Completed14 participants
NCT05821231
Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Registry record
No phaseEnded 1 Sept 2026
Completed1334 participants
NCT05225428
Video Education With Result Dependent dIsclosure
Registry record
Phase 1Ended 26 Aug 2026
Completed215 participants
NCT04084067
Indocyanine Green (ICG) Guided Tumor Resection
Registry record
Phase 2Ended 24 Jul 2026
Completed82 participants
NCT06703346
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Registry record
Phase 1/2Ended 30 Jun 2026
Completed30 participants
NCT05395741
Regorafenib in Patients With Refractory Primary Bone Tumors
Registry record
Phase 2Ended 29 Jun 2026
Completed111 participants
2024-515678-29-00
A phase II study to assess the efficacy of the anti-PD-L1 antibody atezolizumab (MPDL3280A) administered with stereotactic ablative radiotherapy (SABR) in patients with metastatic tumours (SABR-PDL1)
Registry record
Phase 2Ended 29 Jun 2026
Completed138 participants
NCT02992912
Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
Registry record
Phase 1/2Ended 2 Jun 2026
Completed98 participants
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Registry record
Phase 2Ended 28 Apr 2026
Completed73 participants
NCT04025931
Chidamide Combined With Toripalimab in Sarcoma
Registry record
Phase 2Ended 21 Apr 2026
Completed58 participants
NCT04807816
Targeting ATR in Soft-tissue Sarcomas
Registry record
Phase 1Ended 15 Apr 2026
Completed2 participants
NCT03462316
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
Registry record
Phase 3Ended 14 Apr 2026
Completed160 participants
NCT05198934
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation
Registry record
Phase 2Ended 9 Apr 2026
Completed24 participants
NCT01946529
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
Registry record
No phaseEnded 3 Apr 2026
Completed27 participants
NCT05835154
A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
Registry record
Phase 2/3Ended 31 Mar 2026
Completed140 participants
NCT02180867
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Registry record
Phase 3Ended 31 Mar 2026
Completed1645 participants
NCT01371981
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia. · Blood advances, 2026
Registry record
No phaseEnded 31 Mar 2026
Completed186 participants
NCT06073314
Novel Applications for Sarcoma Assessment
Registry record
No phaseEnded 31 Mar 2026
Completed8000 participants
NCT00898365
Study of Kidney Tumors in Younger Patients
- Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. · Pediatric blood & cancer, 2026
Registry record
Phase 2Ended 29 Mar 2026
Completed68 participants
NCT04095208
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Registry record
No phaseEnded 26 Mar 2026
Completed1229 participants
NCT06822842
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
Registry record
No phaseEnded 18 Mar 2026
Completed92 participants
NCT05216029
Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma
Registry record
Phase 2Ended 17 Mar 2026
Completed7 participants
NCT05993299
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Registry record
No phaseEnded 28 Feb 2026
Completed1 participants
NCT07651020
The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
Registry record
Phase 2/3Ended 26 Jan 2026
Completed400 participants
NCT05218499
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Registry record
Phase 1/2Ended 23 Jan 2026
Completed30 participants
NCT04145349
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Registry record
Phase 3Ended 20 Jan 2026
Completed603 participants
NCT03784014
Molecular Profiling of Advanced Soft-tissue Sarcomas
Registry record
Phase 2Ended 16 Jan 2026
Completed34 participants
NCT01391962
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Registry record
Phase 3Ended 31 Dec 2025
Completed642 participants
NCT01231906
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Registry record
No phaseEnded 31 Dec 2025
Completed9 participants
NCT07847268
A First-in-Human Study of ¹⁷⁷Lu-HX02 in Sarcoma Patients
Registry record
Phase 2Ended 31 Dec 2025
Completed70 participants
NCT04172805
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Registry record
Early Phase 1Ended 31 Dec 2025
Completed11 participants
NCT03960177
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Registry record
No phaseEnded 31 Dec 2025
Completed549 participants
NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Registry record
Phase 1/2Ended 19 Dec 2025
Completed39 participants
NCT05301764
A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Registry record
Phase 1/2Ended 18 Dec 2025
Completed40 participants
NCT05708950
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Registry record
Phase 3Ended 12 Dec 2025
Completed138 participants
NCT06058793
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
Registry record
Phase 1Ended 12 Dec 2025
Completed49 participants
NCT01858168
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
Registry record
Phase 2Ended 11 Dec 2025
Completed27 participants
NCT03719430
APX005M and Doxorubicin in Advanced Sarcoma
Registry record
Phase 1Ended 9 Dec 2025
Completed30 participants
NCT05116254
Sarcomas and DDR-Inhibition; a neoadjuvant phase I combined modality study - SADDRIN-1
Registry record
No phaseEnded 1 Dec 2025
Completed2 participants
NCT04540588
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Registry record
Phase 1Ended 28 Nov 2025
Completed21 participants
NCT04619056
First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma
Registry record
Phase 1/2Ended 19 Nov 2025
Completed50 participants
NCT05275478
Study to see how safe is TNG908 at different doses in patients with solid tumors that have a gene called MTAP missing
Registry record
Phase 1/2Ended 30 Oct 2025
Completed30 participants
NCT03526679
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
Registry record
Phase 1/2Ended 22 Oct 2025
Completed30 participants
2024-518529-14-00
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
Registry record
Phase 2Ended 15 Oct 2025
Completed25 participants
2024-512834-14-00
Clinical trial of combined therapy with pembrolizumab and lenvatinib for patients with classic Kaposi sarcoma treated with at least one previous line of chemioterapy.
Registry record
No phaseEnded 5 Oct 2025
Completed63 participants
NCT06171945
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
Registry record
Phase 2Ended 29 Sept 2025
Completed215 participants
NCT02576431
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Registry record
No phaseEnded 4 Sept 2025
Completed54 participants
NCT01449149
Proton Radiation for Chordomas and Chondrosarcomas
Registry record
Phase 1Ended 4 Sept 2025
Completed39 participants
NCT03217266
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Registry record
Phase 2Ended 3 Sept 2025
Completed163 participants
NCT02389244
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Registry record
Phase 1Ended 26 Aug 2025
Completed32 participants
NCT04242238
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Registry record
Phase 1/2Ended 19 Aug 2025
Completed47 participants
NCT04238819
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Registry record
Phase 2Ended 13 Aug 2025
Completed36 participants
2024-513469-38-00
A Window of Opportunity (WoO) study evaluating pembrolizumab with or without olaparib in Tertiary Lymphoid Structures (TLS)-positive selected resectable Soft Tissue Sarcoma (STS) followed by adjuvant pembrolizumab
Registry record
Phase 2Ended 11 Aug 2025
Completed14 participants
NCT05275426
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor
Registry record
Phase 2Ended 6 Aug 2025
Completed128 participants
NCT03709680
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Registry record
No phaseEnded 1 Aug 2025
Completed20 participants
NCT06185738
WeCanManage. An mHealth Self-management Tool
Registry record
No phaseEnded 22 Jul 2025
Completed90 participants
NCT07573072
Characterization of the Methylation Profile of Stored Human Samples
Registry record
Phase 1/2Ended 20 Jul 2025
Completed10 participants
NCT06562673
Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma
Registry record

Not medical advice. fetched 4 Nov 2026

Report an error